Home › Geographic Atrophy › Connecticut
Geographic Atrophy clinical trials in Connecticut
5 studies for Geographic Atrophy are looking for participants at sites in Connecticut.
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Consultants - Manchester, Manchester
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT06541704A Study in Adults With Geographic Atrophy
- Retina Group of New England, PC, Waterford
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Group of New England, Waterford
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Consultants PC, Manchester
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Westport
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03011541From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.